Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000941191 | SCV001087071 | likely benign | Wilson disease | 2024-12-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002292595 | SCV002585449 | likely benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | ATP7B: BP4, BP7 |
All of Us Research Program, |
RCV000941191 | SCV004819208 | likely benign | Wilson disease | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002292595 | SCV005215662 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000941191 | SCV001456185 | uncertain significance | Wilson disease | 2020-02-13 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003960543 | SCV004778249 | likely benign | ATP7B-related disorder | 2019-02-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |